CSF3 and lymphedema: While ketoprofen has the demonstratable ability to decrease dermal thickness and G-CSF in patients, paralleling the murine observations, a black box warning against the prolonged use of NSAIDs was subsequently issued, highlighting the risks of cardiovascular toxicity [137], dampening excitement for the use of ketoprofen in lymphedema.